7.77
price up icon8.07%   0.58
after-market After Hours: 7.55 -0.22 -2.83%
loading

4 D Molecular Therapeutics Inc Stock (FDMT) Forecast

The 4 D Molecular Therapeutics Inc (FDMT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.4002, representing a -69.11% decrease from the current price of $7.77. The highest analyst price target is $1.9902, and the lowest is $2.8102.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FDMT Price Target
Average 7.677 (-1.20% Downside)
loading

Is 4 D Molecular Therapeutics Inc (FDMT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 38.00 Neutral
STOCH(9,6) 19.05 Buy
STOCHRSI(14) 82.11 Sell
MACD(12,26) -0.8362 Sell
ADX(14) 27.82 Sell
William %R -83.30 Buy
CCI(14) -16.57 Neutral
Buy: 2 Sell: 3 Neutral: 2
Summary: Sell
Moving Averages
Period Simple Exponential
MA10
7.631
Buy
7.8349
Sell
MA20
8.8585
Sell
8.5331
Sell
MA50
10.08
Sell
9.2399
Sell
MA100
9.0517
Sell
8.7502
Sell
MA200
6.5045
Buy
8.0486
Sell
Buy: 2 Sell: 8 Neutral: 0
Summary: Sell
According to our latest analysis, FDMT could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on FDMT, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 38 indicates that FDMT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 19.05 indicates that FDMT is oversold. This indicates that FDMT price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 82.11 indicates that FDMT is oversold. This suggests that FDMT price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 27.82 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -16.57 indicates that FDMT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term FDMT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about 4 D Molecular Therapeutics Inc financial reports and earnings history, 4 D Molecular Therapeutics Inc (FDMT) stock could reach $15.44 by 2030, $42.35 by 2040 and $56.00 by 2050. See the projected annual prices until 2050 of the 4 D Molecular Therapeutics Inc stock below:

  • 4 D Molecular Therapeutics Inc (FDMT) is expected to reach an average price of $18.08 in 2035, with a high prediction of $16.97 and a low estimate of $14.75. This indicates an $132.73% rise from the last recorded price of $7.77.
  • 4 D Molecular Therapeutics Inc (FDMT) stock is projected to chart a bullish course in 2040, with an average price target of $43.52, representing an $460.08% surge from its current level. The forecast ranges from a conservative $43.73 to a sky-high $42.35.
  • Our analysts predict 4 D Molecular Therapeutics Inc (FDMT) to jump 767.15% by 2045, soaring from $66.93 to an average price of $67.38, potentially reaching $67.34. While $66.93 is the low estimate, the potential upside is significant.
  • 4 D Molecular Therapeutics Inc (FDMT) stock is expected to climb by 2050, reaching an average of $56.28, a $624.30% jump from its current level. However, a wide range of estimates exists, with high and low targets of $56.00 and $54.99, respectively, highlighting the market's uncertainty.

4 D Molecular Therapeutics Inc Stock (FDMT) Year by Year Forecast

4 D Molecular Therapeutics Inc Stock (FDMT) Price Forecast for 2026

The predicted value for 4 D Molecular Therapeutics Inc (FDMT) in 2026 is set at an average of $7.677. Estimates vary from a peak of $14.98 to a trough of $0.3699, indicating an -1.20% surge from the present price of $7.77.
Month Average Low High Change from today's price
February, 2026 $0.6165 $2.8102 $1.9902 -92.07%
March, 2026 $4.1291 $3.6428 $3.4491 -46.86%
April, 2026 $3.8149 $3.3986 $3.3823 -50.90%
May, 2026 $2.8675 $4.7481 $4.3312 -63.09%
June, 2026 $10.35 $0.3699 $12.49 +33.20%
July, 2026 $11.80 $8.4267 $14.98 +51.92%
August, 2026 $10.63 $7.2915 $11.99 +36.83%
September, 2026 $8.9757 $7.9402 $12.52 +15.52%
October, 2026 $7.7781 $6.0631 $10.58 +0.10%
November, 2026 $6.1405 $3.5399 $8.0768 -20.97%
December, 2026 $6.0247 $2.3178 $12.06 -22.46%

4 D Molecular Therapeutics Inc Stock (FDMT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for 4 D Molecular Therapeutics Inc (FDMT) is $13.06, with a high forecast of $25.93 and a low forecast of $0.1832. This indicates an +68.06% increase from the last price of $7.77.
Month Average Low High Change from today's price
January, 2027 $7.5521 $5.0415 $8.5521 -2.80%
February, 2027 $7.4995 $6.9789 $13.37 -3.48%
March, 2027 $7.7737 $6.9363 $9.85 +0.05%
April, 2027 $5.5811 $4.8934 $8.3005 -28.17%
May, 2027 $5.3185 $4.9035 $6.8579 -31.55%
June, 2027 $0.2427 $0.1973 $6.1253 -96.88%
July, 2027 $1.4901 $0.1832 $1.8151 -80.82%
August, 2027 $2.7174 $0.1938 $3.0774 -65.03%
September, 2027 $10.39 $2.5243 $11.65 +33.74%
October, 2027 $7.7391 $6.8522 $11.71 -0.40%
November, 2027 $17.61 $7.0577 $25.93 +126.60%
December, 2027 $21.99 $16.37 $22.85 +183.02%

4 D Molecular Therapeutics Inc Stock (FDMT) Price Forecast for 2028

In 2028, 4 D Molecular Therapeutics Inc (FDMT) is projected to reach an average price of $13.90, with a high projection of $26.78 and a low estimate of $1.0113. This indicates an +78.87% rise from the last price of $7.77.
Month Average Low High Change from today's price
January, 2028 $16.94 $16.27 $26.78 +117.99%
February, 2028 $16.22 $13.39 $19.04 +108.73%
March, 2028 $18.39 $5.8774 $21.97 +136.74%
April, 2028 $14.27 $11.41 $26.25 +83.65%
May, 2028 $9.558 $6.728 $26.33 +23.01%
June, 2028 $4.8728 $4.6728 $15.60 -37.29%
July, 2028 $1.6125 $2.2764 $11.70 -79.25%
August, 2028 $3.104 $1.8064 $3.016 -60.05%
September, 2028 $3.1093 $4.128 $3.183 -59.98%
October, 2028 $0.3445 $2.5145 $2.4256 -95.57%
November, 2028 $5.034 $1.4166 $6.653 -35.21%
December, 2028 $0.1287 $1.0113 $9.155 -98.34%

4 D Molecular Therapeutics Inc Stock (FDMT) Price Forecast for 2029

The 2029 price forecast for 4 D Molecular Therapeutics Inc Stock (FDMT) is $9.167 on average, with a high prediction of $18.09 and a low estimate of $0.2415. This represents an +17.98% increase from the previous price of $7.77.
Month Average Low High Change from today's price
January, 2029 $2.6628 $0.2415 $7.3372 -65.73%
February, 2029 $4.3981 $2.6054 $2.7081 -43.40%
March, 2029 $6.5033 $4.1707 $3.3344 -16.30%
April, 2029 $9.0285 $5.2159 $6.9975 +16.20%
May, 2029 $10.78 $10.87 $10.60 +38.74%
June, 2029 $12.38 $11.81 $11.50 +59.27%
July, 2029 $10.20 $10.24 $9.6716 +31.28%
August, 2029 $13.14 $10.30 $12.34 +69.14%
September, 2029 $17.20 $14.91 $16.52 +121.33%
October, 2029 $17.52 $17.36 $18.09 +125.47%
November, 2029 $14.27 $16.69 $17.25 +83.71%
December, 2029 $14.60 $14.96 $13.07 +87.89%

4 D Molecular Therapeutics Inc Stock (FDMT) Price Forecast for 2030

4 D Molecular Therapeutics Inc Stock (FDMT) is expected to reach an average price of $8.3277 in 2030, with a high forecast of $16.13 and a low forecast of $0.5229. This signifies an +7.18% surge from the last price of $7.77.
Month Average Low High Change from today's price
January, 2030 $14.81 $15.69 $15.44 +90.62%
February, 2030 $16.54 $15.31 $15.40 +112.82%
March, 2030 $14.78 $14.94 $16.13 +90.24%
April, 2030 $0.3466 $3.1866 $13.65 -95.54%
May, 2030 $1.3681 $0.5229 $3.4782 -82.39%
June, 2030 $2.4334 $2.5407 $0.5916 -68.68%
July, 2030 $1.4649 $1.7549 $1.4249 -81.15%
August, 2030 $6.8101 $3.5975 $3.3801 -12.35%
September, 2030 $5.9254 $6.0891 $4.2028 -23.74%
October, 2030 $3.8669 $5.8469 $4.5417 -50.23%
November, 2030 $3.2022 $3.8022 $2.8122 -58.79%
December, 2030 $3.2774 $1.3548 $2.6452 -57.82%
$102.71
price up icon 28.63%
$33.90
price up icon 2.42%
$110.57
price up icon 3.67%
$100.08
price up icon 2.03%
biotechnology ONC
$333.87
price up icon 4.22%
$176.00
price up icon 0.53%
Cap:     |  Volume (24h):